Zdrowie i gospodarka · 28/10/2005
Oncologic Drugs Advisory Committee to Review and Revise Notice Regarding New Cancer Treatment
The Oncologic Drugs Advisory Committee will review and revise a notice related to a new cancer treatment, following a recent proposal by the FDA to update the notice